Vendor, Bridgewater, NJ, part of Sanofi
Sanofi-Aventis U.S. LLC
UEI VLDVVLDQMML4, CAGE 6TXG7
3 awards and $0 obligated between January 18, 2024 and July 28, 2026, 100% under full and open competition, against 334.0 offers on average where reported. 4 of the awards trace back to a SAM.gov solicitation on this site.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 3 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Human Insulin
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79725R0018Awarded to Sanofi-Aventis U.S. LLC for $465,370,526
Posted May 8, 20254 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36E79724A0021June 27, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | BPA for TzieldNAICS 325412, PSC 6505 | $0 |
| 36E79725D0031May 8, 2025, Full and Open Competition, 2 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | New Award for Human Insulin with Sanofi-Aventis US Llc. Ordering Period Is July 1, 2025 to June 30, 2026 with Four ONE-YEAR Options"NAICS 325412, PSC 6505 | $0 |
| 36F79723D0129January 18, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | FSSNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 63 across 3 awards